The new nasal vaccine only needs one dose and produces reliable immunity right at the site where the virus enters the body.

Arcturus Therapeutics Holdings has won U.S. Food and Drug Administration fast-track designation for its ARCT-2304 pandemic flu vaccine candidate.

Arcturus Therapeutics (ARCT) announced that the FDA has granted fast track designation for the self-amplifying mRNA vaccine candidate, ...

Although most of the reported human infections from the USA so far 1,2 have been mild, the virus can change its profile rapidly ... WHO held a consultation on public health risk mitigation through ...

Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine. During the early COVID-19 pandemic, this platform ...

A 3-year-old girl in western Mexico has died after contracting bird flu in the country's first confirmed human case of the virus, Mexican health authorities said Tuesday. Mexico's Health Ministry said ...

A study in Ontario found no traces of influenza A viral ribonucleic acid (RNA) in 117 samples of pasteurized retail milk collected in April and May 2024, ...

Mexico detected its first human case of H5N1 avian influenza, also known as bird flu, Reuters reported, citing the health ...

The first case of H5N1 bird flu in a human has been reported in Mexico. A three-year-old girl from the state of Durango is ...

The first case of H5N1 bird flu in a human has been reported in Mexico. A three-year-old girl from the state of Durango has ...